Abstract: Peptide sequencing is important in decoding data stored in a data-encoded peptide. Tandem mass spectrometry (MS/MS) is particularly useful for peptide sequencing. In a computer-implemented method for sequencing the data-encoded peptide from an experimental spectrum, raw data of the experimental spectrum are first preprocessed to remove uninterpretable peaks to yield preprocessed data. A first set of one or more candidate sequences contending for a peptide sequence of the peptide is identified from a spectrum graph. The spectrum graph is formed according to the preprocessed data rather than the raw data for generating a fewer number of candidate sequences to thereby reduce a time cost in sequencing. The first candidate-sequence set is then processed to estimate the peptide sequence to thereby obtain a set of peptide-sequence estimate(s). Each estimate is verified whether it is invalid. The set of peptide-sequence estimate(s) is purged to remove any invalid estimate.

Abstract: In one example aspect, a computer-implemented for managing containment behavior of a member during an encounter in a competitive environment includes: receiving, by a computing device, input data relating to the encounter within the competitive environment; determining, by the computing device, a reachable opponent set identifying one or more opponents reachable by the member; determining, by the computing device, containment boundaries for the member based on attributes of the member; determining, by the computing device, one or more containment options based on the containment boundaries and the reachable opponent set; generating, by the computing device, a containment instruction based on a particular one of the one or more containment options; and outputting, by the computing device, the containment instruction to cause the member to move to a position identified in the particular one of the one or more containment options.

Abstract: A composition for coating a polypropylene-based fabric or polypropylene-based material for use in decreasing the transmission of human pathogens. A device such as a protective face mask made from a polypropylene-based fabric or polypropylene-based material coated with the composition.

Abstract: The subject invention provides materials and methods for improving alcohol metabolism in animals. In a preferred embodiment, the invention provides methods for increasing the ability of people to consume alcohol while reducing hangovers or other effects of intoxication. Specifically exemplified herein is the use of a cysteamine compound to reduce the adverse effects of alcohol consumption. For example, the undesirable and unpleasant symptoms association with hangovers can be reduced through consumption, according to the subject invention, of cysteamine hydrochloride.

Abstract: The subject invention provides materials and methods for treating various health conditions, including the prevention and/or treatment of a viral infection. In a preferred embodiment, a cysteamine compound is administered to a subject to treat an influenza virus infection. More preferably, a cysteamine compound is administered to a subject to treat influenza A, influenza B, influenza C virus infections, including avian influenza virus subtypes (such as H5N1 avian influenza virus).

Abstract: A system for pipelined encryption and packetization of audio video (AV) data may consecutively encrypt a number of AV data units based on a security mechanism, associate the encrypted AV data units with a security header, where the security header is generated before the AV data units are encrypted, and the security header includes information related to the security mechanism, generate network packets for transporting the encrypted AV data units and the associated security header based at least in part on an order in which the AV data units are encrypted, where one or more of the network packets is generated contemporaneous with encrypting one or more of the AV data units, and provide the network packets for transport to a client device as the packets are generated, where the AV data units are encrypted and the network packets are generated without accessing memory external to the system.

Abstract: A system and method for processing information may include broadcasting information, which indicates program content for each of a plurality of channels communicated via a plurality of transport streams, to a plurality of processors. The plurality of processors identify which of the program content is associated with a particular one of the plurality of channels in each of the plurality of transport streams. The broadcasted information may be stored in a table in memory. The broadcasted information may include a packet identifier (PID) and/or a processor identifier associated with the PID that identifies at least one of the plurality of processors, such as parsers. The information may be stored in a table in memory prior to the broadcasting. The table may be indexed according to the plurality of channels.

Abstract: A facial mask for use in decreasing the transmission of one or more than one human pathogen to and from a human wearer of the facial mask, the facial mask comprising a facepiece; where the facepiece comprises three or more than three layers; where one or more than one of the three or more than three layers comprises a fabric comprising one or more than one binding substance comprising one or more than one human pathogen binding group for chemically attaching the human pathogen to the binding substance; where the fabric further comprises one or more than one type of multivalent metallic ion or metallic salt; and where one or more than one of the three or more than three layers comprises a heat-moldable fabric.

Abstract: The subject invention provides materials and methods for improving alcohol metabolism in animals. In a preferred embodiment, the invention provides methods for increasing the ability of people to consume alcohol while reducing hangovers or other effects of intoxication. Specifically exemplified herein is the use of a cysteamine compound to reduce the adverse effects of alcohol consumption. For example, the undesirable and unpleasant symptoms association with hangovers can be reduced through consumption, according to the subject invention, of cysteamine hydrochloride.

Abstract: The subject invention provides materials and methods for treating various health conditions, including the prevention and/or treatment of a viral infection. In a preferred embodiment, a cysteamine compound is administered to a subject to treat an influenza virus infection. More preferably, a cysteamine compound is administered to a subject to treat influenza A, influenza B, influenza C virus infections, including avian influenza virus subtypes (such as H5N1 avian influenza virus).

Abstract: The subject invention provides materials and methods for improving alcohol metabolism in animals. In a preferred embodiment, the invention provides methods for increasing the ability of people to consume alcohol while reducing hangovers or other effects of intoxication. Specifically exemplified herein is the use of a cysteamine compound to reduce the adverse effects of alcohol consumption. For example, the undesirable and unpleasant symptoms association with hangovers can be reduced through consumption, according to the subject invention, of cysteamine hydrochloride.

Abstract: The subject invention provides materials and methods for treating various health conditions, including the prevention and/or treatment of a viral infection. In a preferred embodiment, a cysteamine compound is administered to a subject to treat an influenza virus infection. More preferably, a cysteamine compound is administered to a subject to treat influenza A, influenza B, influenza C virus infections, including avian influenza virus subtypes (such as H5N1 avian influenza virus).

Abstract: The subject invention provides materials and methods for modulating a variety of biological factors to treat biological conditions associated with the factors. In one embodiment of the invention, a cysteamine compound is administered to a patient to treat hypercholesterolemia and/or complications associated with hypercholesterolemia. In another embodiment, a cysteamine compound is administered to a patient to prevent the onset of diabetes in an at-risk patient and/or treat or prevent the onset of diabetes-associated complications.

Abstract: The subject invention provides materials and methods for improving alcohol metabolism in animals. In a preferred embodiment, the invention provides methods for increasing the ability of people to consume alcohol while reducing hangovers or other effects of intoxication. Specifically exemplified herein is the use of a cysteamine compound to reduce the adverse effects of alcohol consumption. For example, the undesirable and unpleasant symptoms association with hangovers can be reduced through consumption, according to the subject invention, of cysteamine hydrochloride.

Abstract: The subject invention provides materials and methods for improving alcohol metabolism in animals. In a preferred embodiment, the invention provides methods for increasing the ability of people to consume alcohol while reducing hangovers or other effects of intoxication. Specifically exemplified herein is the use of a cysteamine compound to reduce the adverse effects of alcohol consumption. For example, the undesirable and unpleasant symptoms association with hangovers can be reduced through consumption, according to the subject invention, of cysteamine hydrochloride.

Abstract: A method for securely handling processing of information includes, in a chip, selecting one of a plurality of data processes based on a random index. After a randomly allocated time interval has elapsed, the selected one of the plurality of data processes may be initiated. The selected one of the plurality of data processes may include accessing data and/or acquiring the data. Burstiness of the data may be approximately equal to burstiness of data acquired by at least one of a plurality of clients on the chip. Data may be verified by the selected one of the plurality of data processes prior to the processing of the data.

Abstract: The subject invention provides compositions and methods for treating diabetes in patients. In a preferred embodiment, the invention provides compositions methods for treating diabetes and/or preventing or alleviating complications associated with diabetes. Specifically exemplified herein is the concurrent administration of a cysteamine compound with at least one additional therapeutic agent to prevent and/or treat diabetes as well as prevent and/or treat complications associated with diabetes. In a preferred embodiment, oral administration of cysteamine hydrochloride with Metformin to a patient diagnosed with diabetes can substantially regulate the patient's glucose metabolism and insulin sensitivity.

Abstract: Systems and methods for processing media information are disclosed and may include tracking a number of times that at least one stored identifier that identifies program content for a particular data channel that is received via one of a plurality of multiplexed transport data streams is modified. At least a portion of the received program content for the particular data channel may be discarded based on the tracking. The at least one stored identifier that identifies the program content for the particular data channel may include a packet identifier (PID) and a processor identifier associated with the PID that identifies at least one of a plurality of processors that parses at least a portion of the program content for the particular data channel that is received via one of the plurality of multiplexed transport data streams.

Abstract: A composition for coating a polypropylene-based fabric or polypropylene-based material for use in decreasing the transmission of human pathogens. A device such as a protective face mask made from a polypropylene-based fabric or polypropylene-based material coated with the composition.

Abstract: A method for securely handling processing of information includes, in a chip, selecting one of a plurality of data processes based on a random index. After a randomly allocated time interval has elapsed, the selected one of the plurality of data processes may be initiated. The selected one of the plurality of data processes may include accessing data and/or acquiring the data. Burstiness of the data may be approximately equal to burstiness of data acquired by at least one of a plurality of clients on the chip. Data may be verified by the selected one of the plurality of data processes prior to the processing of the data.